NO20052894D0 - 4-tetrazolyl-4-fenylpiperidin-derivater for behandling av smerte - Google Patents

4-tetrazolyl-4-fenylpiperidin-derivater for behandling av smerte

Info

Publication number: NO20052894D0
Authority: NO; Norway
Prior art keywords: tetrazolyl; pain; treatment; phenylpiperidine derivatives; phenylpiperidine
Prior art date: 2002-11-18

Application number

NO20052894A

Other languages

English (en)

Norwegian (no)

Other versions

NO20052894L (no

Inventor

Zhengming Chen

Original Assignee

Euro Celtique Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-11-18

Filing date

2005-06-14

Publication date

2005-06-14

2005-06-14 Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa

2005-06-14 Publication of NO20052894D0 publication Critical patent/NO20052894D0/no

2005-06-14 Publication of NO20052894L publication Critical patent/NO20052894L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
- C07D211/64—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having an aryl radical as the second substituent in position 4
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Hospice & Palliative Care (AREA)
Otolaryngology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

NO20052894A 2002-11-18 2005-06-14 4-tetrazolyl-4-fenylpiperidin-derivater for behandling av smerte NO20052894L (no)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US42738102P	2002-11-18	2002-11-18
US46027803P	2003-04-03	2003-04-03
US48848803P	2003-07-17	2003-07-17
US10/714,066 US7202259B2 (en)	2002-11-18	2003-11-13	Therapeutic agents useful for treating pain
PCT/US2003/036742 WO2004046132A1 (en)	2002-11-18	2003-11-17	4-tetrazolyl-4phenylpiperidine derivatives for treating pain

Publications (2)

Publication Number	Publication Date
NO20052894D0 true NO20052894D0 (no)	2005-06-14
NO20052894L NO20052894L (no)	2005-06-14

Family

ID=32777221

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20052894A NO20052894L (no)	2002-11-18	2005-06-14	4-tetrazolyl-4-fenylpiperidin-derivater for behandling av smerte

Country Status (37)

Country	Link
US (3)	US7202259B2 (de)
EP (2)	EP1803718B1 (de)
JP (2)	JP4601429B2 (de)
KR (1)	KR20050115221A (de)
CN (2)	CN101648941A (de)
AP (1)	AP2210A (de)
AR (1)	AR047008A1 (de)
AT (2)	ATE402167T1 (de)
AU (2)	AU2003294313B2 (de)
BR (1)	BR0316305A (de)
CA (1)	CA2506242C (de)
CO (1)	CO5690588A2 (de)
CR (2)	CR7877A (de)
CY (2)	CY1107682T1 (de)
DE (2)	DE60322451D1 (de)
DK (2)	DK1803718T3 (de)
EA (1)	EA008621B1 (de)
EC (1)	ECSP055840A (de)
ES (2)	ES2312150T3 (de)
GE (1)	GEP20084539B (de)
HK (1)	HK1086829A1 (de)
IL (1)	IL209352A0 (de)
IS (2)	IS2720B (de)
MA (1)	MA27565A1 (de)
ME (1)	MEP48108A (de)
MX (1)	MXPA05004669A (de)
MY (1)	MY135647A (de)
NI (1)	NI200500087A (de)
NO (1)	NO20052894L (de)
NZ (2)	NZ572685A (de)
OA (1)	OA13010A (de)
PT (2)	PT1803718E (de)
RS (1)	RS51047B (de)
SG (1)	SG165998A1 (de)
SI (2)	SI1562932T1 (de)
TW (2)	TWI343917B (de)
WO (1)	WO2004046132A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7202259B2 (en) *	2002-11-18	2007-04-10	Euro-Celtique S.A.	Therapeutic agents useful for treating pain
US8790689B2 (en) *	2003-04-30	2014-07-29	Purdue Pharma L.P.	Tamper resistant transdermal dosage form
US8778382B2 (en)	2003-04-30	2014-07-15	Purdue Pharma L.P.	Tamper resistant transdermal dosage form
BRPI0506548A (pt) *	2004-01-30	2007-05-02	Euro Celtique Sa	métodos para produzir compostos de 4-tetrazolil-4-fenilpiperidina
SE0401656D0 (sv) *	2004-06-24	2004-06-24	Astrazeneca Ab	Chemical compounds
ATE547414T1 (de) *	2005-11-21	2012-03-15	Purdue Pharma Lp	4-oxadiazolylpiperidinverbindungen und deren verwendung
US20080051380A1 (en)	2006-08-25	2008-02-28	Auerbach Alan H	Methods and compositions for treating cancer
WO2011056561A1 (en)	2009-10-27	2011-05-12	Beth Israel Deaconess Medical Center	Methods and compositions for the generation and use of conformation-specific antibodies
UY33618A (es)	2010-09-21	2012-03-30	Purdue Pharma Lp	Analogos de buprenorfina
CN102648915B (zh) *	2011-02-28	2015-04-15	鲁南制药集团股份有限公司	一种治疗或预防神经病理性疼痛的药物组合物
WO2012149334A2 (en)	2011-04-27	2012-11-01	Beth Israel Deaconess Medical Center, Inc.	Methods and compositions for the generation and use of conformation-specific antibodies
EP2917182B1 (de)	2012-11-09	2018-01-03	Purdue Pharma LP	Benzomorphan-analoge und ihre verwendung
JP6317755B2 (ja)	2012-12-07	2018-04-25	パーデュー、ファーマ、リミテッド、パートナーシップ	オピオイド受容体モジュレーターとしてのブプレノルフィン類似体
WO2014091295A1 (en)	2012-12-14	2014-06-19	Purdue Pharma L.P.	Pyridonemorphinan analogs and biological activity on opioid receptors
ES2621305T3 (es)	2012-12-14	2017-07-03	Purdue Pharma Lp	Morfinanos espirocíclicos y su uso
US9056836B2 (en)	2013-01-31	2015-06-16	Purdue Pharma L.P.	Benzomorphan analogs and the use thereof
US8969358B2 (en)	2013-03-15	2015-03-03	Purdue Pharma L.P.	Buprenorphine analogs
EP3087073B1 (de)	2013-12-26	2018-07-04	Purdue Pharma LP	10-substituierte morphinanhydantoine
WO2015097548A1 (en)	2013-12-26	2015-07-02	Purdue Pharma L.P.	7-beta-alkyl analogs of orvinols
WO2015097545A1 (en)	2013-12-26	2015-07-02	Purdue Pharma L.P.	Opioid receptor modulating oxabicyclo[2.2.2]octane morphinans
WO2015100174A1 (en)	2013-12-26	2015-07-02	Purdue Pharma L.P.	Ring-contracted morphinans and the use thereof
US9340542B2 (en)	2013-12-26	2016-05-17	Purdue Pharma L.P.	Propellane-based compounds and the use thereof
WO2015099863A1 (en)	2013-12-27	2015-07-02	Purdue Pharma L.P.	6-substituted and 7-substituted morphinan analogs and the use thereof
CA2950567A1 (en)	2014-05-27	2015-12-03	Purdue Pharma L.P.	Spirocyclic morphinans and use thereof
EP3154972A4 (de)	2014-06-13	2017-11-22	Purdue Pharma L.P.	Azamophinanderivate und verwendung davon
MA41125A (fr)	2014-12-05	2017-10-10	Purdue Pharma Lp	Dérivés de 6.7-cyclomorphinane et leur utilisation
MA43834A (fr)	2016-03-22	2018-11-28	Univ Minnesota	Combinaison pour traiter la douleur
CN119606966A (zh)	2016-07-29	2025-03-14	詹森药业有限公司	治疗前列腺癌的方法
US10745402B2 (en)	2017-01-02	2020-08-18	Purdue Pharma L.P.	Morphinan derivatives and use thereof
CN117750958A (zh) *	2021-05-21	2024-03-22	普渡制药公司	治疗间质性膀胱炎/膀胱疼痛综合征的方法
WO2023250190A1 (en) *	2022-06-24	2023-12-28	Purdue Pharma L.P.	Methods of treating or preventing overactive bladder syndrome

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3536809A (en) *	1969-02-17	1970-10-27	Alza Corp	Medication method
US3598122A (en) *	1969-04-01	1971-08-10	Alza Corp	Bandage for administering drugs
US3598123A (en) *	1969-04-01	1971-08-10	Alza Corp	Bandage for administering drugs
BE775611A (fr)	1970-11-24	1972-03-16	Synthelabo	Derives de la (diphenyl-3,3 propyl-1)-1 piperidine, leur preparation etles medicaments qui en contiennent
US4076717A (en) *	1971-12-15	1978-02-28	G. D. Searle & Co.	Derivatives of 1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylic acid
US3845770A (en) *	1972-06-05	1974-11-05	Alza Corp	Osmatic dispensing device for releasing beneficial agent
US3916899A (en) *	1973-04-25	1975-11-04	Alza Corp	Osmotic dispensing device with maximum and minimum sizes for the passageway
US4008719A (en) *	1976-02-02	1977-02-22	Alza Corporation	Osmotic system having laminar arrangement for programming delivery of active agent
IE58110B1 (en) *	1984-10-30	1993-07-14	Elan Corp Plc	Controlled release powder and process for its preparation
DK162087D0 (da) *	1987-03-31	1987-03-31	Ferrosan As	Piperidinforbindelser, deres fremstilling og anvendelse
US4831192A (en) *	1987-12-31	1989-05-16	Boc, Inc.	Methods of preparing 4-heteropentacyclic-4-(N-phenyl)amido) piperidine derivatives and intermediate compounds
US5073543A (en) *	1988-07-21	1991-12-17	G. D. Searle & Co.	Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
IT1229203B (it) *	1989-03-22	1991-07-25	Bioresearch Spa	Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
US5120548A (en) *	1989-11-07	1992-06-09	Merck & Co., Inc.	Swelling modulated polymeric drug delivery device
US5733566A (en) *	1990-05-15	1998-03-31	Alkermes Controlled Therapeutics Inc. Ii	Controlled release of antiparasitic agents in animals
US5698155A (en) *	1991-05-31	1997-12-16	Gs Technologies, Inc.	Method for the manufacture of pharmaceutical cellulose capsules
US5580578A (en) *	1992-01-27	1996-12-03	Euro-Celtique, S.A.	Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5449989A (en)	1992-07-31	1995-09-12	Correa; Paulo N.	Energy conversion system
US5606037A (en)	1992-11-09	1997-02-25	Biochem Pharma Inc.	Processes antineoplastic heteronaphthoquinones
US5736523A (en)	1992-11-09	1998-04-07	Biochem Pharma Inc.	Antineoplastic heteronapthoquinones
US5591767A (en) *	1993-01-25	1997-01-07	Pharmetrix Corporation	Liquid reservoir transdermal patch for the administration of ketorolac
IT1270594B (it) *	1994-07-07	1997-05-07	Recordati Chem Pharm	Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
US6166085A (en)	1995-04-14	2000-12-26	The Regents Of The University Of California	Method of producing analgesia
US5849737A (en)	1995-04-14	1998-12-15	The Regents Of The University Of California	Compositions and methods for treating pain
EP0833622B8 (de) *	1995-06-12	2005-10-12	G.D. Searle & Co.	Mittel, enthaltend einen cyclooxygenase-2 inhibitor und einen 5-lipoxygenase inhibitor
US6573282B1 (en)	1995-09-12	2003-06-03	Adolor Corporation	Peripherally active anti-hyperalgesic opiates
US5849761A (en)	1995-09-12	1998-12-15	Regents Of The University Of California	Peripherally active anti-hyperalgesic opiates
AU1208397A (en)	1995-12-28	1997-07-28	Takeda Chemical Industries Ltd.	Diphenylmethane derivatives as mip-1alpha/rantes receptor antagonists
US6221888B1 (en)	1997-05-29	2001-04-24	Merck & Co., Inc.	Sulfonamides as cell adhesion inhibitors
ATE200781T1 (de) *	1997-06-10	2001-05-15	Synthon Bv	4-phenylpiperidin-derivate
SK13092000A3 (sk)	1998-03-06	2001-03-12	Janssen Pharmaceutica N. V.	Inhibítory prenosu glycínu, spôsob ich prípravy, farmaceutický prostriedok s ich obsahom a ich použitie
US6423519B1 (en) *	1998-07-15	2002-07-23	Gpc Biotech Inc.	Compositions and methods for inhibiting fungal growth
US7217714B1 (en)	1998-12-23	2007-05-15	Agouron Pharmaceuticals, Inc.	CCR5 modulators
PE20001420A1 (es)	1998-12-23	2000-12-18	Pfizer	Moduladores de ccr5
AU771273B2 (en)	1999-03-12	2004-03-18	Boehringer Ingelheim Pharmaceuticals, Inc.	Compounds useful as anti-inflammatory agents
AU7315800A (en)	1999-09-20	2001-04-24	Takeda Chemical Industries Ltd.	Mch antagonists
CA2324330A1 (en)	1999-11-08	2001-05-08	Ssp Co., Ltd.	4-hydroxy-4-phenylpiperidine derivatives and pharmaceuticals containing the same
WO2001039775A1 (en)	1999-12-06	2001-06-07	Euro-Celtique, S.A.	Benzimidazole compounds having nociceptin receptor affinity
WO2001046206A1 (en)	1999-12-22	2001-06-28	Merck Frosst Canada & Co.	Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1b (ptp-1b)
US6608052B2 (en)	2000-02-16	2003-08-19	Boehringer Ingelheim Pharmaceuticals, Inc.	Compounds useful as anti-inflammatory agents
US6703525B2 (en)	2000-02-16	2004-03-09	Boehringer Ingelheim Pharmaceuticals, Inc.	Sulfonamide intermediates and methods of producing same
WO2001070689A1 (fr) *	2000-03-24	2001-09-27	Meiji Seika Kaisha, Ltd.	DERIVES DE LA DIPHENYLALKYLAMINE UTILES COMME AGONISTES DU RECEPTEUR DE L'OPIOIDE $g(d)
US6544981B2 (en)	2000-06-09	2003-04-08	Bristol-Myers Squibb Company	Lactam inhibitors of factor Xa and method
CN1469862A (zh)	2000-10-12	2004-01-21	Ss制药株式会社	2,2-二苯基丁酰胺衍生物和含有它的药物
WO2002038185A2 (en)	2000-11-13	2002-05-16	Atrix Laboratories, Inc.	Injectable sustained release delivery system with loperamide
US7202259B2 (en) *	2002-11-18	2007-04-10	Euro-Celtique S.A.	Therapeutic agents useful for treating pain
BRPI0506548A (pt) *	2004-01-30	2007-05-02	Euro Celtique Sa	métodos para produzir compostos de 4-tetrazolil-4-fenilpiperidina

2003
- 2003-11-13 US US10/714,066 patent/US7202259B2/en not_active Expired - Lifetime
- 2003-11-17 EA EA200500726A patent/EA008621B1/ru not_active IP Right Cessation
- 2003-11-17 ES ES07006697T patent/ES2312150T3/es not_active Expired - Lifetime
- 2003-11-17 WO PCT/US2003/036742 patent/WO2004046132A1/en active Search and Examination
- 2003-11-17 AU AU2003294313A patent/AU2003294313B2/en not_active Ceased
- 2003-11-17 DK DK07006697T patent/DK1803718T3/da active
- 2003-11-17 NZ NZ572685A patent/NZ572685A/en not_active IP Right Cessation
- 2003-11-17 GE GEAP20038846A patent/GEP20084539B/en unknown
- 2003-11-17 DE DE60322451T patent/DE60322451D1/de not_active Expired - Lifetime
- 2003-11-17 DE DE60313021T patent/DE60313021T2/de not_active Expired - Lifetime
- 2003-11-17 AP AP2005003297A patent/AP2210A/xx active
- 2003-11-17 EP EP07006697A patent/EP1803718B1/de not_active Expired - Lifetime
- 2003-11-17 NZ NZ540068A patent/NZ540068A/en not_active IP Right Cessation
- 2003-11-17 BR BR0316305-9A patent/BR0316305A/pt not_active IP Right Cessation
- 2003-11-17 RS YUP-2005/0375A patent/RS51047B/sr unknown
- 2003-11-17 AT AT07006697T patent/ATE402167T1/de active
- 2003-11-17 CA CA2506242A patent/CA2506242C/en not_active Expired - Fee Related
- 2003-11-17 AT AT03789796T patent/ATE358674T1/de active
- 2003-11-17 DK DK03789796T patent/DK1562932T3/da active
- 2003-11-17 CN CN200910173679A patent/CN101648941A/zh active Pending
- 2003-11-17 OA OA1200500145A patent/OA13010A/en unknown
- 2003-11-17 PT PT07006697T patent/PT1803718E/pt unknown
- 2003-11-17 KR KR1020057008903A patent/KR20050115221A/ko active IP Right Grant
- 2003-11-17 ME MEP-481/08A patent/MEP48108A/xx unknown
- 2003-11-17 MX MXPA05004669A patent/MXPA05004669A/es active IP Right Grant
- 2003-11-17 EP EP03789796A patent/EP1562932B9/de not_active Expired - Lifetime
- 2003-11-17 JP JP2004570427A patent/JP4601429B2/ja not_active Expired - Fee Related
- 2003-11-17 PT PT03789796T patent/PT1562932E/pt unknown
- 2003-11-17 SI SI200330814T patent/SI1562932T1/sl unknown
- 2003-11-17 SG SG200703631-2A patent/SG165998A1/en unknown
- 2003-11-17 SI SI200331358T patent/SI1803718T1/sl unknown
- 2003-11-17 ES ES03789796T patent/ES2285235T3/es not_active Expired - Lifetime
- 2003-11-17 CN CNB2003801035027A patent/CN100567288C/zh not_active Expired - Fee Related
- 2003-11-18 TW TW092132303A patent/TWI343917B/zh not_active IP Right Cessation
- 2003-11-18 TW TW096151468A patent/TW200819436A/zh unknown
- 2003-11-18 MY MYPI20034402A patent/MY135647A/en unknown
- 2003-11-19 AR ARP030104269A patent/AR047008A1/es unknown
2005
- 2005-04-19 IS IS7812A patent/IS2720B/is unknown
- 2005-04-22 NI NI200500087A patent/NI200500087A/es unknown
- 2005-05-20 CO CO05048789A patent/CO5690588A2/es not_active Application Discontinuation
- 2005-06-07 EC EC2005005840A patent/ECSP055840A/es unknown
- 2005-06-13 MA MA28335A patent/MA27565A1/fr unknown
- 2005-06-14 NO NO20052894A patent/NO20052894L/no not_active Application Discontinuation
- 2005-06-16 CR CR7877A patent/CR7877A/es unknown
2006
- 2006-06-14 HK HK06106822.5A patent/HK1086829A1/xx not_active IP Right Cessation
2007
- 2007-03-28 US US11/729,660 patent/US7687518B2/en not_active Expired - Lifetime
- 2007-06-21 CY CY20071100825T patent/CY1107682T1/el unknown
2008
- 2008-10-16 CY CY20081101151T patent/CY1108422T1/el unknown
2009
- 2009-09-21 CR CR11037A patent/CR11037A/es not_active Application Discontinuation
- 2009-11-10 US US12/615,510 patent/US8026254B2/en not_active Expired - Lifetime
2010
- 2010-03-12 JP JP2010056560A patent/JP2010163452A/ja active Pending
- 2010-07-21 IS IS8913A patent/IS8913A/is unknown
- 2010-11-16 IL IL209352A patent/IL209352A0/en unknown
- 2010-11-25 AU AU2010246411A patent/AU2010246411A1/en not_active Abandoned

Also Published As

Publication number	Publication date
CA2506242A1 (en)	2004-06-03
EA200500726A1 (ru)	2005-10-27
AP2005003297A0 (en)	2005-06-30
EA008621B1 (ru)	2007-06-29
AU2003294313B2 (en)	2010-08-26
DE60322451D1 (de)	2008-09-04
CA2506242C (en)	2011-07-05
US8026254B2 (en)	2011-09-27
EP1562932B9 (de)	2007-09-12
SG165998A1 (en)	2010-11-29
EP1562932A1 (de)	2005-08-17
CY1107682T1 (el)	2013-04-18
WO2004046132A1 (en)	2004-06-03
US20100069437A1 (en)	2010-03-18
SI1803718T1 (sl)	2008-12-31
MXPA05004669A (es)	2005-06-08
CR11037A (es)	2009-10-29
DK1562932T3 (da)	2007-08-13
DE60313021T2 (de)	2007-12-13
DE60313021D1 (de)	2007-05-16
NI200500087A (es)	2007-07-24
CN1711256A (zh)	2005-12-21
GEP20084539B (en)	2008-11-25
KR20050115221A (ko)	2005-12-07
AR047008A1 (es)	2006-01-04
IL209352A0 (en)	2011-01-31
ATE358674T1 (de)	2007-04-15
AU2010246411A1 (en)	2010-12-16
SI1562932T1 (sl)	2007-08-31
ES2312150T3 (es)	2009-02-16
US7687518B2 (en)	2010-03-30
MA27565A1 (fr)	2005-10-03
ATE402167T1 (de)	2008-08-15
AP2210A (en)	2011-02-25
EP1803718A1 (de)	2007-07-04
NZ572685A (en)	2010-06-25
JP2006525944A (ja)	2006-11-16
RS51047B (sr)	2010-10-31
EP1803718B1 (de)	2008-07-23
MY135647A (en)	2008-06-30
NO20052894L (no)	2005-06-14
TWI343917B (en)	2011-06-21
JP4601429B2 (ja)	2010-12-22
CN101648941A (zh)	2010-02-17
AU2003294313A1 (en)	2004-06-15
IS8913A (is)	2010-07-21
PT1803718E (pt)	2008-09-26
TW200819436A (en)	2008-05-01
US20040152689A1 (en)	2004-08-05
OA13010A (en)	2006-11-10
ES2285235T3 (es)	2007-11-16
IS7812A (is)	2005-04-19
CY1108422T1 (el)	2014-04-09
US20070179141A1 (en)	2007-08-02
EP1562932B1 (de)	2007-04-04
MEP48108A (en)	2011-02-10
RS20050375A (en)	2007-11-15
DK1803718T3 (da)	2008-10-27
JP2010163452A (ja)	2010-07-29
US7202259B2 (en)	2007-04-10
TW200418828A (en)	2004-10-01
ECSP055840A (es)	2005-08-11
IS2720B (is)	2011-02-15
HK1086829A1 (en)	2006-09-29
CN100567288C (zh)	2009-12-09
CR7877A (es)	2005-11-30
CO5690588A2 (es)	2006-10-31
BR0316305A (pt)	2005-09-27
NZ540068A (en)	2007-07-27
PT1562932E (pt)	2007-07-02

Publication	Publication Date	Title
NO20052894D0 (no)	2005-06-14	4-tetrazolyl-4-fenylpiperidin-derivater for behandling av smerte
NO20044054L (no)	2004-11-24	Administrering av midler for behandling av betennelse
NO20053077D0 (no)	2005-06-23	Terapeutiske formuleringer for behandling av beta-amyloid-relaterte sykdommer.
NO20043237L (no)	2004-08-02	Dihydrobenzodiazepin-2-onderivater for behandling av neurologiske forstyrrelser
GB0312832D0 (en)	2003-07-09	2-amino-pyridine derivatives useful for the treatment of diseases
NO20013380L (no)	2001-09-07	2-aminobenzoksazinonderivater for behandling av fedme
NO20013381D0 (no)	2001-07-06	2-oksybenzoksazinonderivater for behandling av fedme
EP1534074A4 (de)	2008-01-09	Kombinationstherapie zur behandlung von fettleibigkeit
IS7691A (is)	2005-02-09	Lyfjasamsetningar til að meðhöndla æxli
NO20024775D0 (no)	2002-10-03	Hydroksyfenyl-piperidin-4-yliden-metyl-benzamidderivater til behandling av smerte
NO20063443L (no)	2006-09-27	Piperziner effektive for behandling av smerte
NO20045554L (no)	2004-12-20	Fremgangsmate for behandling av diabetes
PT1487828E (pt)	2009-01-06	Derivados de morfolinil-ureia para utilização no tratamento de doenças inflamatórias
NO20053623D0 (no)	2005-07-26	Derivater av prostaglandiner for behandling av abdominalt ubehag
NO20033804D0 (no)	2003-08-26	Karbamatforbindelser for behandling av smerte
NO20055098D0 (no)	2005-11-01	Anvendelse av 10-hydroksy-10,11-dihydrokarbamazepinderivater for behandling av affektive forstyrrelser
NO20024777L (no)	2002-12-03	Kinolinyl-piperidin-4-yliden-metyl-benzamid derivater til behandling av smerte
NO20024776D0 (no)	2002-10-03	Hydroksyfenyl-piperazinyl-metyl-benzamidderivater til behandling av smerte
DE60315490D1 (de)	2007-09-20	Therapeutische behandlung
NO20043445L (no)	2004-08-18	Kombinasjonsterapi for behandling av bakterielle infeksjoner
NO20020784D0 (no)	2002-02-18	Medikament for behandling av brudd
NO20040497L (no)	2004-04-14	Amidinderivater for behandling av amyloidose
DK1567524T3 (da)	2009-11-16	Thia-epothilonderivater til behandling af cancer
NO20033290D0 (no)	2003-07-21	Pyrrolderivater for behandling av cytokinformidlede sykdommer
NO20033160D0 (no)	2003-07-10	Anordning for behandling av gravann

Legal Events

Date	Code	Title	Description
2012-01-02	FC2A	Withdrawal, rejection or dismissal of laid open patent application